U.S. Wireless Telecom Stock News

Once Upon A Farm PBC (OFRM) drew fresh investor attention after issuing 2026 net sales guidance of US$302 million to US$310 million, following its fourth quarter and full year 2025 results and new product launches. See our latest analysis for Once Upon A Farm PBC. Despite the strong fourth quarter figures, 2026 outlook and new product launches, Once Upon A Farm PBC’s recent share price performance has cooled, with a 1 day share price return of 7.27% decline and a 30 day share price return of...

In March 2026, GlobalFoundries’ largest shareholder Mubadala completed a secondary offering of 20,000,000 ordinary shares at US$42 each, while the company itself received no proceeds but concurrently executed a US$300,000,000 repurchase as part of its existing buyback authorization. This combination of a major shareholder sell-down and a company-funded buyback reshapes GlobalFoundries’ ownership mix and highlights management’s willingness to deploy balance sheet cash to support capital...

Order-driven interest in Aehr Test Systems Aehr Test Systems (AEHR) is back on investors’ radar after securing a US$14 million order for its FOX-XP wafer-level test systems from a leading AI processor customer, tying the story closely to data center hardware demand. See our latest analysis for Aehr Test Systems. At a share price of US$35.67, the stock has recently pulled back 5.26% on a 1 day share price return, but that comes after a 23.68% 1 month share price return and a very large 1 year...

In March 2026, BioNTech SE reported fourth-quarter 2025 sales of €907.4 million with a net loss of €305 million, issued 2026 revenue guidance of €2.0–€2.3 billion, and confirmed that co-founders CEO Ugur Sahin and CMO Özlem Türeci will leave by the end of 2026 to launch a new mRNA-focused company. An unusual element of this transition is that BioNTech plans to contribute selected mRNA rights and technologies to the founders’ new venture in exchange for a minority stake, while asserting that...

In recent trading, MDU Resources Group appeared on a technical breakout scan with a strong trend and consolidation pattern, while Natixis Advisors LLC very largely increased its shareholding in the company during the third quarter. Together, the powerful technical setup and heightened institutional participation highlight how both chart-based and fundamental investors are paying closer attention to MDU Resources Group. We’ll now consider how this sharp rise in institutional ownership could...

Why Chefs' Warehouse Is Back on Investors' Radar Chefs' Warehouse (CHEF) has drawn fresh attention after management recently emphasized the company's resilience. They pointed to ongoing technology investments, facility expansion, and acquisition integration as key themes in its latest update. See our latest analysis for Chefs' Warehouse. The latest update appears to have supported sentiment, with a 1-day share price return of 0.98% and a 7-day share price return of 2.70%. However, the 30-day...

In recent days, InnovAge Holding Corp. was upgraded by Zacks Investment Research to a Rank #1 (Strong Buy) after analysts raised their earnings estimates and signaled improving confidence in the company’s earnings outlook. This upgrade, alongside earlier technical signals such as a hammer chart pattern, points to a shift in how the market is interpreting InnovAge’s evolving fundamentals and earnings revisions. We will now examine how InnovAge’s upgrade to a Zacks Rank #1 (Strong Buy) may...

Amicus Therapeutics (FOLD) has been drawing attention after a strong past 3 months, with a total return of 32.1% and 61.5% over the past year, prompting fresh questions about what is driving sentiment. See our latest analysis for Amicus Therapeutics. The current share price of $14.37 comes after a relatively quiet few weeks in terms of short term share price movement. However, the 90 day share price return of 32.08% alongside a 1 year total shareholder return of 61.46% suggests that momentum...

Illumina (ILMN) is back in focus after the company and Nashville Biosciences expanded the Alliance for Genomic Discovery to 312,000 whole genomes and launched a 50,000 sample genome proteomics pairing initiative. See our latest analysis for Illumina. Illumina’s recent Alliance for Genomic Discovery expansion and multiomic push come as the share price sits at US$118.94, with a 1-day share price return of 2.92% but a year to date share price return decline of 11.47%. The 1-year total...

VEON Ltd. has reported past fourth-quarter 2025 revenue of US$1,171 million, up from US$998 million a year earlier, but swung to a net loss of US$31 million for the quarter even as full-year 2025 net income increased to US$532 million on higher sales of US$4,399 million. Alongside this, VEON set out 2026 guidance targeting total revenue growth of 9%–12% in US$ terms and expanded its digital and AI partnerships across key markets, including Uzbekistan, Pakistan, Bangladesh, and broader...

Copa Holdings (CPA) is back in focus after a sharp share price drop over the past month, mixed analyst rating changes, and upward earnings estimate revisions ahead of the airline operator’s next results update. See our latest analysis for Copa Holdings. The recent 24.33% 1 month share price decline to US$110.38 follows a series of mixed analyst rating changes and higher earnings estimates. However, the 1 year total shareholder return of 25.47% and 3 year total shareholder return of 52.87%...

If you are trying to figure out whether StoneCo at around US$13.81 is a bargain or a trap, you are in the right place to focus on what the current price really reflects. The stock has had a mixed ride, with a 0.7% return over the last 7 days, an 18.1% decline over 30 days, a 6.0% decline year to date, a 42.1% return over 1 year and 55.7% over 3 years, while still sitting 79.4% below its 5-year level. Recent headlines around StoneCo have largely centered on its role in Brazil's payments and...

T1 Energy (TE) has been in focus after investor optimism picked up ahead of its upcoming fourth quarter and full year 2025 earnings release, along with fresh support from Section 45X tax credit eligibility. See our latest analysis for T1 Energy. The recent rally, including a 13.39% 7 day share price return and 50.59% 90 day share price return to US$7.62, has coincided with Section 45X tax credit support and earnings anticipation. At the same time, the year to date share price return shows a...

MSCI (MSCI) is back in focus after Snowden Lane Partners said it will integrate the MSCI Wealth Manager platform into its advisory ecosystem, putting the company’s portfolio analytics and tax aware tools in front of more advisors. See our latest analysis for MSCI. MSCI’s shares trade at US$547.90, with a 30 day share price return of 4.15% after a softer 7 day share price return of 3.75%, while the 1 year total shareholder return of 0.10% and 5 year total shareholder return of 40.84% point to...

Intel (NasdaqGS:INTC) reported multi billion dollar losses in its foundry business for 2025, with management indicating break even is not expected until at least 2027. The Client Computing Group saw shrinking revenue and high margin CPU share losses to AMD, while overall company revenue declined last quarter. Foundry segment sales grew, but Intel now guides to a sequential revenue decline and projects zero near term earnings, citing supply constraints. Recent product launches and new...

Multiple class action lawsuits have been filed against monday.com in the past week. Complaints focus on alleged misstatements about revenue growth momentum and expansion outlook. Investor groups claim recent guidance and business shifts exposed earlier disclosures as misleading. The cases target monday.com ordinary shares traded on NasdaqGS:MNDY. monday.com, which trades on NasdaqGS:MNDY, is now dealing with legal pressure alongside a challenging share price history. The stock closed at...

Chairman Michael Moritz and Chief Product & Design Officer David Fock have recently made significant insider share purchases in Klarna Group, NYSE:KLAR. The buying activity comes as Klarna's post IPO lockup period expires, opening the door for early investors and insiders to sell shares. Klarna is expanding its embedded resale integration with eBay to additional markets and working with Stripe to support flexible payments in AI agent driven shopping journeys. Klarna Group, NYSE:KLAR, is...

Earlier this month, CareTrust REIT, Inc. increased its quarterly common stock cash dividend from US$0.335 to US$0.39 per share, payable to stockholders of record as of March 31, 2026, with payment intended around April 15, 2026. This higher dividend highlights management’s emphasis on returning more cash to shareholders, a key consideration for income-focused real estate investors assessing the REIT’s appeal. We’ll now examine how this higher quarterly dividend payout fits into CareTrust...

Recent share performance and business snapshot Otis Worldwide (OTIS) has drawn investor attention after a mixed stretch for the share price, with negative moves over the past week, month, past 3 months, year to date, and the past year. Behind that, the elevator and escalator group reports annual revenue of US$14.4b and net income of US$1.4b, with reported annual revenue growth of 4.63% and net income growth of 11.14%. This is prompting a closer look at the stock. See our latest analysis for...

WeRide (NasdaqGM:WRD) shareholders approved a comprehensive governance overhaul at an extraordinary general meeting. The company adopted a fully updated memorandum and articles of association and refreshed its equity and share mandate framework. A new 2026 Share Plan was also approved, setting fresh parameters for future equity-based incentives. WeRide, listed as NasdaqGM:WRD, operates in autonomous driving and related mobility solutions. In this sector, access to capital and board...

In recent days, AdaptHealth Corp. disclosed that major shareholder Richard M. Cashin Jr. purchased about 2,046,691 additional shares of the company’s common stock, lifting his reporting group’s stake to 15,864,871 shares in a transaction worth nearly US$20,000,000. This sizeable insider purchase by a 10% owner comes shortly after AdaptHealth reported a quarterly earnings per share of US$0.76, which fell well short of expectations even as revenue slightly exceeded forecasts, drawing attention...

If you are wondering whether DENTSPLY SIRONA is attractively priced at its current level, this article walks through what the numbers say about the stock’s value. The share price last closed at US$11.54, with returns of a 9.4% decline over 7 days, a 10.9% decline over 30 days, a 2.4% gain year to date, and a 22.2% decline over 1 year. The 3 year and 5 year returns stand at a 65.8% decline and a 79.5% decline respectively. These moves have kept DENTSPLY SIRONA in focus for investors watching...

What Syndax Pharmaceuticals (SNDX) Investors Are Watching Right Now Syndax Pharmaceuticals (SNDX) has drawn fresh attention after recent trading, with the stock closing at US$23.50 and showing double digit total returns over the past year and the past 3 months. See our latest analysis for Syndax Pharmaceuticals. That latest 1 day share price decline of 2.04% comes after a strong run, with a 30 day share price return of 14.75% and 1 year total shareholder return of 81.47%. This suggests...

In recent weeks, TransMedics Group reported fourth-quarter results that exceeded analyst expectations and updated investors with what analysts described as a strong 2026 outlook. Analysts highlighted the company’s continued investment in heart and lung transplant technology and its intention to expand into kidney, underscoring confidence in its clinical platform. Building on this upbeat outlook and kidney expansion focus, we’ll now explore how the latest developments may reshape TransMedics’...